Literature DB >> 15894703

No association between BRCA2 N372H and breast cancer risk.

David G Cox1, Susan E Hankinson, David J Hunter.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15894703     DOI： 10.1158/1055-9965.EPI-04-0848

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN： 1055-9965            Impact factor:   4.254


× No keyword cloud information.
  13 in total

1.  Polymorphisms in DNA double-strand break repair genes and risk of breast cancer: two population-based studies in USA and Poland, and meta-analyses.

Authors:  Montserrat García-Closas; Kathleen M Egan; Polly A Newcomb; Louise A Brinton; Linda Titus-Ernstoff; Stephen Chanock; Robert Welch; Jolanta Lissowska; Beata Peplonska; Neonila Szeszenia-Dabrowska; Witold Zatonski; Alicja Bardin-Mikolajczak; Jeffery P Struewing
Journal:  Hum Genet       Date:  2006-02-17       Impact factor: 4.132

2.  Clinical and molecular features associated with biallelic mutations in FANCD1/BRCA2.

Authors:  Blanche P Alter; Philip S Rosenberg; Lawrence C Brody
Journal:  J Med Genet       Date:  2006-07-06       Impact factor: 6.318

3.  Novel sequence variants and common recurrent polymorphisms of BRCA2 in Sri Lankan breast cancer patients and a family with BRCA1 mutations.

Authors:  Sumadee DE Silva; Kamani H Tennekoon; Eric H Karunanayake; Wasanthi DE Silva; Indrani Amarasinghe; Preethika Angunawela
Journal:  Exp Ther Med       Date:  2011-08-17       Impact factor: 2.447

4.  Risk of contralateral breast cancer associated with common variants in BRCA1 and BRCA2: potential modifying effect of BRCA1/BRCA2 mutation carrier status.

Authors:  Jane C Figueiredo; Jennifer D Brooks; David V Conti; Jenny N Poynter; Sharon N Teraoka; Kathleen E Malone; Leslie Bernstein; Won D Lee; David J Duggan; Ashley Siniard; Patrick Concannon; Marinela Capanu; Charles F Lynch; Jørgen H Olsen; Robert W Haile; Jonine L Bernstein
Journal:  Breast Cancer Res Treat       Date:  2010-12-15       Impact factor: 4.872

5.  Risk of non-Hodgkin lymphoma (NHL) in relation to germline variation in DNA repair and related genes.

Authors:  Deirdre A Hill; Sophia S Wang; James R Cerhan; Scott Davis; Wendy Cozen; Richard K Severson; Patricia Hartge; Sholom Wacholder; Meredith Yeager; Stephen J Chanock; Nathaniel Rothman
Journal:  Blood       Date:  2006-07-20       Impact factor: 22.113

6.  Do-it-yourself genetic testing.

Authors:  Steven L Salzberg; Mihaela Pertea
Journal:  Genome Biol       Date:  2010-10-07       Impact factor: 13.583

7.  Association of follicular lymphoma risk with BRCA2 N372H polymorphism in Slovak population.

Authors:  Ján Salagovič; Lucia Klimčáková; Denisa Ilenčíková; Adriana Kafková
Journal:  Med Oncol       Date:  2011-04-08       Impact factor: 3.064

8.  A common missense variant in BRCA2 predisposes to early onset breast cancer.

Authors:  Bohdan Górski; Steven A Narod; Jan Lubinski
Journal:  Breast Cancer Res       Date:  2005-10-24       Impact factor: 6.466

9.  Common variants in the ATM, BRCA1, BRCA2, CHEK2 and TP53 cancer susceptibility genes are unlikely to increase breast cancer risk.

Authors:  Caroline Baynes; Catherine S Healey; Karen A Pooley; Serena Scollen; Robert N Luben; Deborah J Thompson; Paul D P Pharoah; Douglas F Easton; Bruce A J Ponder; Alison M Dunning
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

10.  Association between the BRCA2 N372H variant and male breast cancer risk: a population-based case-control study in Tuscany, Central Italy.

Authors:  Domenico Palli; Mario Falchetti; Giovanna Masala; Ramona Lupi; Francesco Sera; Calogero Saieva; Cristina D'Amico; Marco Ceroti; Piera Rizzolo; Maria Adelaide Caligo; Ines Zanna; Laura Ottini
Journal:  BMC Cancer       Date:  2007-09-03       Impact factor: 4.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.